A first-of-its-kind survey of people who lost Medicaid coverage last year found just over half made no effort to renew their coverage — in many cases because they were unable to navigate paperwork requirements.
FDA Relents, Approves Novel Antidepressant After Many Rejections
After multiple prior rejections, gepirone hydrochloride extended-release (ER; Exxua) gained FDA approval for the treatment of major depressive disorder (MDD) in adults, drugmaker Fabre-Kramer Pharmaceuticals